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Abstract 
The disruption of protein folding homeostasis in the endoplasmic reticulum (ER) results in an 
accumulation of toxic misfolded proteins and activates a network of signaling events 
collectively known as the unfolded protein response (UPR). While UPR activation upon ER 
stress is well characterized, how other signaling pathways integrate into the ER proteostasis 
network is unclear. Here, I sought to investigate how the target of rapamycin complex 1 
(TORC1) signaling cascade acts in parallel with the UPR to regulate ER stress sensitivity. 
Using S. cerevisiae, I found that TORC1 signaling is attenuated during ER stress and 
constitutive activation of TORC1 increases sensitivity to ER stressors such as tunicamycin 
and inositol deprivation. This phenotype is independent of the UPR. Transcriptome analysis 
revealed that TORC1 hyperactivation results in cell wall remodeling. Conversely, 
hyperactive TORC1 sensitizes cells to cell wall stressors, including the antifungal 
caspofungin.  Elucidating the crosstalk between the UPR, cell wall integrity, and TORC1 
signaling may uncover new paradigms through which the response to protein misfolding is 
regulated, and thus have crucial implications for the development of novel therapeutics 
against pathogenic fungal infections. 
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1.1 The Role of ER Homeostasis in Human Pathology 
A number of environmental and genetic conditions can impair protein-folding fidelity in 
the endoplasmic reticulum (ER), leading to a build-up of misfolded proteins within the 
organelle– a condition known as ER stress1–3. To restore protein-folding homeostasis, the 
cell activates a network of intracellular signaling events known as the unfolded protein 
response (UPR)2–4. Chronic ER stress and malfunctions in UPR signaling have emerged 
as key contributors to a number of human diseases such as neurodegeneration 5,6, cancer7–
9, and pathogenic fungal infections10–13; however, what remains unclear is how these 
signaling pathways mediate disease progression.  
A hallmark of the pathology of neurodegeneration is the accumulation of protein 
aggregates and misfolded proteins within neurons and surrounding cells. For example, in 
Parkinson’s disease, ubiquitinated protein aggregates of -synuclein form characteristic 
Lewy bodies14. Additionally, Alzheimer’s disease is characterized by both extracellular 
deposits of the amyloid- protein, as well as intracellular deposits of tau protein15. As a 
whole, the common theme between these neurological diseases is that the accumulation 
of misfolded proteins disrupts protein-folding homeostasis in the ER. While ER stress-
driven neurotoxicity is well established, what remains to be understood are the signaling 
pathways and mechanisms that mediate these diseases. 
Similarly, the role of ER stress in cancer is well established, but poorly understood16,17. 
Tumor cells often grow in unfavourable conditions such as hypoxia, inadequate nutrition, 
and oxidative stress – all of which compromise protein folding within the ER16,17. As a 
result, sustained activation of UPR signaling and increased expression of downstream 
UPR targets are prevalent in a wide array of human tumors including glioblastomas and 
carcinomas of the breast, stomach, and liver7–9. Despite the vast amount of evidence 
implicating ER stress and UPR activation in cancer, how these processes inhibit or 
promote tumor growth, remains to be understood.  
Additionally, pathogenic fungi, such as Aspergillus fumigatus – the leading agent of 
fungal infections in immunocompromised patients, rely heavily on the secretory pathway 
to mediate cell wall integrity and enzyme secretion during infection18. Recent studies 
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suggest a direct role for the ER in facilitating essential fungal traits such as biofilm 
formation and virulence10,12,18. Furthermore, the inability of pathogenic fungi to cause 
disease when their ER stress responses11,18 are impaired suggests that targeting molecules 
that disrupt these stress pathways could be useful in developing novel anti-fungal 
therapies. Therefore, elucidating the signaling pathways that interact with the UPR under 
conditions of ER stress will facilitate our understanding of ER-stress related disease 
progression. 
1.2 Secretory Pathway Homeostasis 
The ER is a membrane-bound organelle responsible for the synthesis, post-translational 
modification, folding, and quality control of secretory proteins2,19,20. Secretory protein 
translation is initiated by cytosolic ribosomes; however, the emergence of a signal 
peptide allows the polypeptide to be recognized by a signal recognition particle (SRP), 
which directs the ribosome to the ER21,22. Once the ribosome becomes bound to the ER 
membrane, polypeptide synthesis continues, and the polypeptide enters the ER lumen co-
translationally. The environment of the ER lumen is highly specialized for protein 
folding; not only does the oxidizing potential support disulphide bond formation, but the 
high concentration of chaperone proteins also helps to minimize protein aggregation and 
facilitate native structure formation20,23,24. While the processes of protein folding and 
maturation are assisted, they are also sensitive to changes in ER homeostasis, such as 
altered metabolic states, increases in protein synthesis, and the expression of misfolded 
proteins25. Conditions that perturb ER homeostasis generate a state known as ER stress, 
which can compromise cell integrity due to the accumulation of misfolded proteins2,4,26. 
Therefore, to ensure protein-folding fidelity, cells have evolved an ER quality control 
mechanism, ER-associated degradation (ERAD), that ensures that only properly folded 
proteins are trafficked to the Golgi apparatus, and that misfolded proteins are targeted to 
the proteasome for degradation27–30. If, however, the accumulation of misfolded proteins 
exceeds the capacity of the ER quality control machinery, the cell enters a state of stress 
and elicits a network of intracellular signaling and transcriptional events that are 
collectively known as the unfolded protein response (UPR)2,4.  
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1.3 Endoplasmic Reticulum Stress 
Depending on the physiological state of the cell, the flux of polypeptides into the ER can 
be highly dynamic. Therefore, to preserve protein-folding fidelity, cells adjust the 
protein-folding capacity of the ER to meet cellular demands. However, ER homeostasis 
can be perturbed by both physiological and pathological conditions such as nutrient 
deprivation, high protein demand,  or mutant protein expression – all of which can result 
in an accumulation of unfolded or misfolded proteins in the ER lumen, a condition 
termed ER stress31–33. Additionally, several chemicals induce ER stress in a cell culture 
system, including tunicamycin and dithiothreitol (DTT). Tunicamycin blocks the initial 
step of glycoprotein biosynthesis in the ER by inhibiting UDP-GlcNAc-phosphate 
transferase34. Therefore, treatment with tunicamycin causes an accumulation of misfolded 
glycoproteins in the ER, consequently leading to UPR activation. DTT is a potent 
reducing agent that disrupts the formation of disulfide bonds between cysteine residues 
and causes unfolded proteins to accumulate in the ER35–37. 
Changes in lipid metabolism also activate the UPR, independently of the response caused 
by an accumulation of misfolded proteins in the ER 38,39. The observation that the ER 
protein folding sensor, Ire1, lacking its luminal misfolded protein-sensing domain, was 
activated in yeast deprived of lipid precursors provides direct evidence that lipids activate 
ER stress response programs independently of their effects on the misfolded protein 
burden in the ER lumen 40,41. Furthermore, in yeast studies, where cells were depleted of 
phospholipid building blocks, chaperone protein mobility was significantly increased 
compared to ER stress conditions where the accumulation of misfolded proteins in the 
ER lumen slowed down chaperone protein mobility38. Taken together, these observations 
suggest that altering lipid metabolism activates the UPR independently of unfolded 
protein levels, implying that multiple modes of UPR activation may exist. 
In particular, the phospholipid building block, inositol, plays an essential role in the 
interplay between lipid metabolism and ER stress signaling2,42. Perturbations in inositol 
metabolism are associated with the activation of several key stress response pathways 
such as the UPR and cell wall integrity (CWI) pathways42–44. In fact, early studies 
showing that mutations in the UPR pathway confer inositol auxotrophy, highlight the 
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notion that stress response signaling is activated by inositol starvation. The depletion of 
inositol triggers the ER stress sensor, Ire1, which induces the transcription of inositol 
biosynthetic genes such as INO1, the enzyme that catalyzes the rate limiting step of 
inositol synthesis3,45. The regulation of INO1 transcription, itself, is mediated by the 
repressor protein, Opi1 (Fig. 1.1). Normally, under conditions of high inositol, Opi1 
translocates from the ER to the nucleus, where it represses INO1 transcription42. On the 
other hand, low concentrations of inositol prevent Opi1 translocation and thus allow 
expression of INO142. While it is unclear how exactly inositol deprivation triggers ER 
stress, some studies postulate that it triggers the UPR by either causing changes in the 
lipid composition of the ER membrane46 or by impairing membrane trafficking44,47. 
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Figure 1.1: The regulation of INO1 transcription is mediated by the repressor 
protein, Opi1. 
In the absence of inositol, the Opi1 repressor is maintained in the ER by phosphatidic 
acid (PA). This allows for the expression of INO1 (left). In the presence of inositol, the 
cell does not need to expend cellular energy to synthesize inositol, therefore Opi1 
dissociates from PA and translocates to the nucleus, where it prevents INO1 transcription 
(right). 
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1.4 Unfolded Protein Response 
ER stress is the imbalance between the protein folding capacity and the protein folding 
load in the ER. The cellular response to this imbalance is the activation of the UPR, 
which restores ER homeostasis through three primarily adaptive mechanisms: 1) 
attenuation of protein translation to reduce the protein load entering the ER, 2) 
transcriptional activation of UPR genes to increase protein folding capacity, and 3) 
stimulation of membrane lipid synthesis to expand ER volume2,4,26. If ER stress is 
prolonged, and ER homeostasis cannot be re-established, then a fourth mechanism, cell 
death, is elicited2,26,48. 
In mammals, perturbations in ER homeostasis are sensed and transduced to the cytoplasm 
and nucleus via three ER-resident sensors: inositol requiring enzyme 1 (Ire1), activating 
transcription factor 6 (ATF6), and pancreatic ER eIF2α kinase (PERK; Fig. 1. 2A)1,4,26,49. 
These three sensors share similar structures in that they all harbor luminal, 
transmembrane, and cytoplasmic domains. In the absence of ER stress the ER chaperone, 
binding immunoglobulin protein (BiP), binds to the luminal domain of the three sensors, 
thereby maintaining their inactive states50–52. In response to an accumulation of misfolded 
proteins during ER stress, BiP dissociates from the sensors in order to bind misfolded 
proteins, and thereby activates and initiates UPR signaling. Of the three sensors, Ire1, is 
the most conserved branch of the UPR. Following dissociation from BiP, Ire1 
oligomerizes, allowing for transautophosphorylation of adjacent kinase domains, and 
stimulation of cytosolic endoribonuclease activity1,4,45,53. Once activated, Ire1 excises an 
intron from the mRNA of its only known substrate, X-box binding protein 1 (XBP1), 
thereby generating an active transcription factor. The spliced variant of XBP1 then 
translocates to the nucleus where it binds to an unfolded protein response element 
(UPRE) in the promoter sequence of a number of UPR-target genes, thereby regulating 
their expression. Genes that are regulated by XBP1 include those that mediate ER protein 
folding, quality control, ERAD, and membrane expansion54,55. In addition to the selective 
cleavage of XBP1 mRNA, Ire1 also alleviates ER stress by reducing protein synthesis 
through regulated Ire1-dependent decay (RIDD), wherein it degrades a subset of ER-
localized mRNA25. Further examination of proteins that bind UPR promoter elements led 
9 
 
to the identification of the second protein folding sensor, ATF6. While ATF6 is normally 
an ER-resident protein, under conditions of ER stress, it is trafficked to the Golgi 
apparatus where it is cleaved into an active transcription factor56. This transcription factor 
then translocates to the nucleus where it increases the expression of ER-resident 
molecular chaperones and folding enzymes such as BiP, calreticulin, and protein 
disulfide isomerase 57. Finally, the third protein folding sensor, PERK, exerts its function 
by phosphorylating a component of the translation initiation complex, eukaryotic 
initiation factor 2 (eIF2α). When eiF2α is phosphorylated, it prevents the downstream 
formation of the ternary initiation complex eIF2-GTP-tRNAMETi, and thereby leads to 
global attenuation of protein translation58–60.  
Unlike mammals, the sole ER stress sensor in S. cerevisiae is Ire1; however, it functions 
in a manner similar to Ire1 in metazoans in terms of its cytosolic endonuclease 
activity2,3,61(Fig 1.2B). Upon induction of ER stress, the BiP homologue, Kar2, 
dissociates from the luminal domain of Ire1, allowing it to oligomerize, 
transautophosphorylate, and activate its cytosolic RNase activity2–4. Ire1 then splices 
HAC1 mRNA to generate a functional variant of the transcript, which upon translation 
functions as a transcription factor to upregulate genes involved in ER quality control 
machinery, ribosome biogenesis, and ERAD components2,3. Previous literature has also 
suggested a role for Hac1 in mediating membrane expansion and lipid biogenesis62,63. 
Taken together, the yeast model of the UPR provides a simplified but representative 
model through which ER stress signaling may be investigated.  
Interestingly, unlike S. cerevisiae, Schizosaccharomyces pombe, lack both HAC1/XBP1 
orthologs and a UPR-dependent transcriptional program64. Instead, under conditions of 
ER stress, S. pombe relies exclusively on two means of Ire1-dependent post 
transcriptional regulation: 1) RIDD, and 2) processing of Bip1 mRNA within its 
3’UTR64. The processing of Bip1 mRNA stabilizes Bip1 and ensures that it is present at 
an increased steady state concentration, without increasing transcription64. As such, S. 
pombe corrects the protein folding imbalance by decreasing the protein folding load in 
the ER. Given that the RIDD function of Ire1 in S. pombe is conserved in higher 
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eukaryotes64, exploring how it impacts yeast tolerance to ER stressors could be useful in 
understanding the pathways that mediate protein folding homeostasis. 
Although the UPR is well characterized, what remains unclear is how it integrates with 
other signaling pathways under conditions of ER stress. Interestingly, a reciprocal 
connection has been identified between the cell wall integrity (CWI) and ER stress 
pathways65–67.  
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(A) The mammalian UPR consists of three protein folding sensors: PERK, ATF6, and Ire1. 
(B) S. cerevisiae UPR.  Ire1 is highly conserved from yeast to mammals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Representative schematic of the unfolded protein response (UPR). 
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1.5 Convergence of the UPR and CWI Pathways 
Within an external environment, fungi face numerous environmental stressors such as 
low nutrient availability and changes in pH and temperature12,68. As such, the fungal cell 
wall acts as the first line of defense, providing a rigid cellular boundary to withstand 
internal turgor pressure and extracellular stresses. Proper cell wall architecture requires 
three major components: β 1-3-glucan, chitin, and mannoproteins– all of which come 
together to form a large macromolecular complex 69,70. In response to environmental 
stress, the coordinated synthesis of cell wall components occurs through the cell wall 
integrity (CWI) pathway, which plays an essential role in maintaining cell wall 
homeostasis12,71,72. While the main components of the CWI pathway are conserved in 
most species of fungi, the foundational understanding of the CWI pathway stems from 
studies in S. cerevisiae 71,73–78. In S. cerevisiae, under conditions of cell wall stress, the 
CWI pathway responds through a signaling cascade that links cell-surface sensors, Wsc1, 
Mid2, and Mtl1, to a series of intracellular signaling molecules including the Rho1 
GTPase, which binds and activates Pkc1, which in turn activates the MAPK signaling 
cascade, including Bck1, Mkk1/2, and Mpk1/Slt273,74,76 (Fig. 1.3). Phosphorylated Slt2 
then translocates to the nucleus where it regulates the expression of cell-wall genes 
through two distinct pathways: 1) the Rlm1 transcription factor; or 2) the Swi4/6 complex 
(Fig.1.3). Slt2 activation of the Rlm1 transcription factor allows for the regulation of a 
number of genes involved in cell wall homeostasis including GPI proteins and chitin 
synthases79. Similarly, Slt2 activation of the Swi4/6 complex not only allows for the 
transcription of cell-wall related genes like β 1-3-glucan synthases Fks1 and Fks2, but 
also mediates cell-cycle related genes 80.  
Defects in the CWI pathway leads to cell lysis when yeast are exposed to environmental 
conditions that impair cell wall stability such as high temperature 81 or disruptions in cell 
wall synthesis 82. More specifically, loss of function of any component downstream of 
Pkc1 leads to cell lysis at elevated growth temperatures; however, this growth defect is 
osmoremedial, with the addition of 1M sorbitol, consistent with a defect in cell wall 
biogenesis 83,84. Furthermore, mutants in the CWI pathway are more sensitive to cell wall 
antagonists such as Calcofluor white 85,86, Congo red 87, and caffeine 88. 
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Interestingly, the CWI pathway and secretory pathway are reciprocally affected under 
conditions of environmental stress12,89,90. In this regard, defects in CWI cause increased 
sensitivity to ER stress and impairments in secretory pathway homeostasis disrupt cell 
wall composition. Surprisingly, deletions in genes involved in the  CWI pathway, 
particularly BCK1 and SLT2, cause extreme sensitivity to the ER stressors, tunicamycin 
and DTT66. This suggests that to compensate for cell wall defects during cell wall stress, 
the CWI pathway may upregulate a number of cell wall proteins, thereby increasing the 
protein flux through the ER, and contributing to ER stress. Conversely, ER homeostasis 
is required for proper cell wall biogenesis and for mediating resistance to the cell wall-
targeting drug, caspofungin67. Fungal mutants lacking HAC1  or IRE1 exhibit increased 
sensitivity to the cell wall antagonists, Calcofluor white and Congo red91. This suggests 
that ER stress may compromise the fidelity of cell wall proteins, impair biogenesis of cell 
wall constituents, and consequently activate the CWI pathway. Taken together, the 
coordination of a number of pathways may be responsible for mediating sensitivity to 
environmental stressors. 
It is also important to note that both cell wall biogenesis and protein folding in the ER are 
highly energetically demanding processes and, as such, low nutrient status is a potent 
trigger of the UPR40. Thus, the interconnection between metabolic regulation and the 
UPR is a crucial area of study, one that has thus far been inadequately addressed. 
Accumulating evidence suggests that the cellular metabolism mediating AMPK signaling 
cascade and its subsequent regulation of crucial proteins acetyl-CoA carboxylase and 
mTOR, may cooperate with the UPR to mediate cell viability under conditions of ER 
stress40,42,49; however, the mechanisms behind this crosstalk remain to be elucidated. 
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In yeast cells, the CWI signaling cascade mediates the transcription of cell wall genes by 
transducing signals from outer membrane sensors to intracellular effector proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Representative schematic of the cell wall integrity (CWI) pathway in 
S. cerevisiae 
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1.6 ER homeostasis and TORC1 Signaling 
The target of rapamycin (TOR) is an evolutionarily conserved serine/threonine kinase 
that functions at the core of signaling networks involved in cell growth, metabolism, and 
nutrient and hormone sensing92,93. These signaling networks mediate anabolism and 
catabolism by coordinating a number of cellular and metabolic processes such as 
transcription, protein translation, ribosome biogenesis, and cellular architecture94–97.  
TOR kinase genes were originally identified by mutations that conferred resistance to the 
growth inhibitory properties of the drug, rapamycin, in budding yeast, Saccharomyces 
cerevisiae 92. Unlike yeast which possess two TOR genes (TOR1 and TOR2), higher 
eukaryotes contain only one TOR gene (mTOR). Nevertheless, the functional domains 
within these proteins are highly conserved (Fig. 1.4A). TOR genes encode relatively large 
(~280kDa) proteins that have a conserved C-terminal phosphatidylinositol kinase (PIK) 
homology domain, an FKBP12-rapamycin binding (FRB) domain, about 20 tandemly 
repeated HEAT motifs to mediate protein-protein interactions, and FAT and FATC 
domains which serve as important protein-protein regulators and catalytic activity 
mediators, respectively97,98. In all eukaryotes, these TOR kinases are the central 
component of two distinct complexes: TOR complex 1 (TORC1) and TOR complex 2 
(TORC2), of which only TORC1 is rapamycin sensitive95. 
In particular, TORC1 in yeast has a size of ~2MDa and consists of four main proteins: 
Kog1, Lst8, Tco89 and either TOR1 or TOR2 (Fig. 1.4B)99,100. Localization studies 
demonstrate that TORC1 is localized to the yeast vacuole and that changes in localization 
are not necessary for TORC1 signaling 101,102. A major breakthrough in the field came 
from the discovery that rapamycin treatment alters cell physiology in a manner similar to 
nutrient starvation, such that treatment with rapamycin resulted in a decrease in protein 
synthesis, induction of apoptosis, and entrance into a quiescent G0 state92. This 
observation was the first indication that TORC1 plays an important role in mediating cell 
growth in response to cell nutrient status. In general, TORC1 is responsible for promoting 
ribosome biogenesis, cell proliferation, and protein anabolism. In addition to mediating 
anabolic processes, TORC1 also promotes cell growth by inhibiting a number of stress 
response pathways94,103,104. To date, the best characterized substrate of TORC1 in yeast is 
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Sch9, the yeast homolog for the AGC kinase, S6K, and monitoring the phosphorylation 
status of this protein is an indicator of TORC1 activity101. Additionally, the 
phosphorylation of RPS6, a downstream target of Sch9, is regulated in a TORC1-
dependent manner and serves as a valid readout for TORC1 activity in vivo105,106. Recent 
reports indicate that under conditions of cell stress, Sch9 and RPS6 phosphorylation is 
dramatically reduced; however, it is unclear how these stress signals are transduced to 
TORC1103,105,106.  
Interestingly cells treated with rapamycin activate the CWI pathway, suggesting that the 
TORC1 signaling pathway not only impinges upon the CWI pathway, but also negatively 
regulates the pathway107,108. Therefore, while initially thought to be distinct pathways, 
recent research points to a functional interaction between the UPR, TORC1, and CWI 
signaling pathways104,107–109. Nevertheless, the manner in which the CWI, UPR, and TOR 
signaling pathways interact remains to be elucidated. Given that these signaling pathways 
are all essential for facilitating fungal pathogenesis, understanding the manner in which 
these pathways act in parallel to mediate ER homeostasis may allow us to uncover novel 
targets for antifungal drugs. 
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Figure 1.4: Representative schematic of the TOR1 Kinase and TORC1 complex. 
A) Conserved structure of TOR kinases. The functional domains of TOR include tandem 
HEAT repeats, the FAT domain, the FRB-rapamycin binding domain, the PIK 
homologous kinase domain, and the FATC domain. B) Representative schematic of the 
TORC1 complex. The central component of the complex is the TOR1 kinase. 
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1.7 Cellular Pathways mediating Pathogenic Fungal 
Infections 
The prevalence of pathogenic fungal infections, coupled with the emergence of new 
fungal pathogens, has rapidly brought these diseases to the forefront of global health 
problems 13. Nearly 2 billion people are afflicted by fungal infections worldwide, 
resulting in 1.5 million deaths annually 110,111. While most individuals will suffer from 
generally treatable superficial fungal infections, of particular concern are the millions of 
people worldwide that will contract life-threating invasive infections – diseases with a 
mortality rate which exceeds 50%, even with the availability of antifungal treatments 
111,112. Despite the wide-spread prevalence of these diseases, the study of fungal 
infections is greatly lacking when compared to other infectious diseases. As such, there is 
a pressing need for research in this field to explore the cellular pathways mediating 
infection in order to facilitate the development of novel therapeutics. 
The most widespread group of superficial mycoses are fungal infections of the skin and 
nails, affecting nearly 25% of the world’s population112. These infections are primarily 
caused by the fungal agents, dermatophytes, and give rise to conditions such as athlete’s 
foot, ringworm of the scalp, and infection of the nails 112. Other superficial fungal 
infections include mucosal infections of the oral and genital tract, such as oropharyngeal- 
or vulvovaginal candidiasis respectively, commonly known as thrush113,114. The vast 
majority of these superficial mucosal infections are caused by several species of Candida, 
the second most prevalent fungal species worldwide 113–115. Individuals who are 
particularly susceptible to mucosal fungal infections include transplant patients, 
individuals diagnosed with leukemia, and patients who have undergone radiotherapy111. 
While superficial fungal infections are relatively well managed with antifungals, 
recurrent infections show decreased sensitivity to antifungal compounds110,114 and bring 
forth the problem of fungal resistance. 
While the incidence of invasive fungal infections (IFI) is significantly lower than that of 
superficial fungal infections, IFI pose a much greater threat because of their high 
mortality rates111,116. The large majority of deaths caused by invasive fungi are often 
attributed to opportunistic infections, such that fungal pathogens take advantage of hosts 
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with a compromised immune system. As such, patients with the greatest risk of 
contracting these life-threatening infections include those diagnosed with 
immunosuppressive diseases such as asthma and HIV/AIDs 117–119 or those treated with 
immunosuppressive medical interventions such as chemotherapy and radiation 120.  As a 
whole, the aetiological agents responsible for more than 90% of IFI-related deaths fall 
largely within four genera of fungi: Cryptococcus, Candida, Aspergillus, and 
Pneumocytis 111,121. While antifungal treatments have advanced over the last decade, 
patient outcomes have not substantially improved 122. These shortcomings are largely 
attributed to the evolutionary similarity between fungi and humans, which limits the 
scope of drug development against fungal specific targets. As such, there is a pressing 
need to understand the unique cellular mechanisms that govern fungal viability.  
Since the cell wall is essential for fungal survival and its composition is unique to the 
fungal organism, this structure acts as an ideal target for antifungal drugs123. Notably, 
echinocandins represent the first class of antifungal drugs that specifically target the 
fungal cell wall124,125. In particular, the echinocandin caspofungin acts as a fungicide by 
noncompetitively inhibiting the β 1-3-glucan synthases, Fks1 and Fks2, thereby blocking 
cell wall synthesis126. Genome-wide microarray analysis of yeast cells treated with 
caspofungin revealed that treatment with this drug rapidly and specifically triggers 
induction of CWI related genes70. This observation was confirmed by Northern blot 
analysis, which demonstrated that caspofungin induced Slt2 phosphorylation70. 
Moreover, cells with deletions in crucial CWI genes, Slt2, Bck1, Pkc1, and Fks1/2, were 
all hypersensitive to caspofungin, suggesting that integrity of CWI pathway is required 
for tolerance to caspofungin70. Notably, caspofungin also induced the expression of the 
chitin synthase, Chs1p70. This is in line with previous studies, which reported that cells 
lacking Fks1/2 have a compensatory mechanism induced, resulting in higher chitin and 
mannoprotein content 127–129. Given the dual regulation of Fks1/2 by the calcineurin 
pathway128,130 (Fig. 1.5), it was also interesting to note that caspofungin caused repression 
of the calcineurin gene, CNA1 70,131. Furthermore, pathogenic fungi rely heavily on the 
secretory pathway to govern tolerance to antifungal drugs132,133, mediate cell wall 
homeostasis134,135, and express virulence136. Therefore, exploring the connection between 
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the CWI pathway, UPR, and nutrient sensing TOR pathway, is integral for understanding 
the pathways that mediate fungal pathogenesis.  
Given that S. cerevisiae is evolutionarily related to a number of pathogenic fungi, and in 
particular to the Candida species137, most genes from S. cerevisiae are highly conserved 
in pathogenic fungal strains. This conserved homology makes S. cerevisiae an ideal 
model system to identify signal transduction and metabolic pathways required for fungal 
survival in the host environment. Among the shared genomic features includes similar 
mechanisms for cell wall homeostasis138–140 and activation of stress responses141. 
Therefore, S. cerevisiae is a powerful tool to analyze the integration of cellular pathways 
that mediate fungal viability. 
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The calcium/calcineurin signaling pathway and the CWI pathway dually regulate 
expression of FKS2 gene expression under conditions of cell wall or high calcium stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Ca2+/Calcineurin signaling and CWI converge to mediate FKS2 gene 
expression. 
26 
 
1.8 Hypothesis 
My central hypothesis is that attenuation of TORC1 signaling during ER stress is 
required for β 1-3 glucan synthase expression and adaptation to proteotoxic stress. 
Overall, the goal of this research is to better understand the cross-talk between the TOR 
signaling pathway, cell wall integrity pathways, and the UPR, and how the interplay 
between these pathways mediates ER stress sensitivity (Fig. 1.6). 
Both TORC192 and UPR3,142 signaling were initially characterized in yeast and are 
conserved in higher eukaryotes. Therefore, I rationalized that employing the model 
organism, Saccharomyces cerevisiae, would be a powerful tool to investigate the 
interplay between the UPR and other signaling networks. Among the advantages of 
employing yeast is that it is a genetically and biochemically tractable model organism 
that allows for rapid and extensive genetic manipulation. Taken together, yeast will 
provide an excellent platform to analyze the integration of cellular pathways during ER 
stress. 
1.9 Objectives 
To study my hypothesis, I have three main objectives: 
Objective 1: Determine the effect of TORC1 signaling on ER stress sensitivity 
Objective 2: Examine how hyperactivation of TORC1 signaling sensitizes cells to ER 
stressors 
Objective 3: Determine the role of TORC1 signaling in mediating cell wall integrity 
during ER stress 
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It is unclear how TORC1 signaling acts in parallel with the UPR to mediate ER stress 
sensitivity. We seek to investigate whether TORC1 signaling has a role in mediating cell 
wall architecture, ribosomal biogenesis, and UPR integrity during ER stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: TORC1 signaling during ER stress. 
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2.1 Introduction 
The ability of cells to respond to detrimental stresses, such as an aberrant accumulation of 
toxic misfolded proteins, dictates cell fate under both normal and pathological conditions. 
Loss of secretory protein homeostasis due to pharmacological, genetic, or environmental 
perturbations activates a plethora of adaptive responses to help cells overcome the stress 
1,2.  In yeast, the ER resident protein Ire1 detects changes in the ER misfolded protein and 
activates a transcriptional response termed the unfolded protein response (UPR; 3–7. Upon 
induction of ER stress, the ER chaperone, Kar2, dissociates from the luminal domain of 
Ire1, allowing it to oligomerize, trans-autophosphorylate, and subsequently activate its 
cytosolic RNase activity 4,5,8–10. Ire1 then splices HAC1 mRNA to generate a functional 
variant of the transcript, which upon translation functions as a transcription factor to 
upregulate genes involved in ER quality control machinery and ribosome biogenesis 5,8. 
Cellular adaptation to ER stress is not only dependent on the amplitude of the UPR 
signal, but also on the selective expression of UPR target genes capable of overcoming a 
particular stress condition 11. Interestingly, Pincus et al. (2014) show that S. cerevisiae 
amplify the UPR with time delayed Ras/PKA signaling, indicating that the response to 
ER stress is not limited to the UPR 12. Moreover, induction of ER stress activates 
transcription of genes associated with other types of stress responses 2.  Therefore, 
elucidating how the UPR integrates with other signaling pathways under conditions of 
ER stress is essential to understand how proteostasis is mediated in the cell. 
Given that protein folding in the ER is a highly energetically demanding process, low 
nutrient status is a potent trigger of the UPR 13. Therefore, the interconnection between 
metabolic regulation and the UPR is a crucial area of study, one that has thus far been 
inadequately addressed. Accumulating evidence suggests that the cellular metabolism 
mediating AMPK signaling cascade and its subsequent regulation of crucial proteins 
acetyl-CoA carboxylase and TOR, may cooperate with the UPR to mediate cell viability 
under conditions of ER stress 13–15; however, the mechanisms behind this crosstalk 
remain to be elucidated. In yeast, TORC1 inhibition with rapamycin protects yeast cells 
from ER stress-induced vacuolar fragmentation and promotes antifungal synergism 16. In 
addition, pharmacological induction of ER stress triggers autophagy, a process negatively 
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regulated by TORC1 17. It therefore appears that TOR signaling is an important 
determinant of the yeast ER stress response.  
In S. cerevisiae, TOR kinases are evolutionarily conserved serine/threonine kinases that 
function at the core of signaling networks involved in cell growth, metabolism, and 
nutrient and hormone sensing 18,19. These TOR kinases are the central component of two 
distinct complexes: TOR complex 1 (TORC1) and TOR complex 2 (TORC2), of which 
only TORC1 is rapamycin sensitive 20. In particular, the TORC1 signaling network 
mediates anabolism and catabolism by coordinating cellular and metabolic processes 
such as transcription, protein translation, ribosome biogenesis, and cellular architecture 
20–23. In addition to mediating anabolic processes, TORC1 promotes cell growth by 
inhibiting a number of stress response pathways 21,24,25. Nevertheless, the manner in 
which the secretory and TORC1 signaling pathway act in parallel, under conditions of ER 
stress, remains to be elucidated.  
To study the effect of TORC1 signaling on protein folding homeostasis, we employed a 
hyperactive variant of the TOR1 kinase (TOR1L2134M) 15 and assessed yeast sensitivity to 
ER stress. We elucidate a novel interplay between proteostasis and TORC1 signaling and 
show that attenuation of TORC1 signaling is required for adaptation to ER stress. On the 
other hand, constitutive activation of TORC1 confers increased sensitivity to ER 
stressors, including the antifungal caspofungin, by compromising cell wall architecture. 
Our study, therefore, expands the role of ER homeostasis beyond the UPR and defines 
how TORC1 signaling contributes to the ER stress response.  
 
2.2 Materials and Methods 
2.2.1 Yeast Strains and Methods 
The Saccharomyces cerevisiae strains and plasmids used in this study are listed in Tables 
2.1 and 2.2, respectively. All yeast strains are derivatives of BY4742. The TS161 (TOR1) 
and TS184 (TOR1L2134M) strains were kind gifts from Dr. Maeda24. BY4742 or 
derivatives were thawed from frozen stocks and grown on YPD (yeast extract peptone 
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dextrose) or selective SC (synthetic complete) media for 2 days at 30C before being 
transferred to liquid cultures. All experiments were carried out using either SC media 
containing 2% wv-1 glucose supplemented with 100x inositol or YPD media. Cultures 
were grown at 30C with constant agitation or on selective agar plates. 
Table 2.1: Yeast Strains 
Strains Genotype Reference 
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 26, 27 
TS161 Wild-type TOR MATα ura3-52 24 
TS184 Mutant TOR MATα ura3-52 TOR1L2134M 24 
 BY4742 ire1Δ 
 
MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
IRE1::KAN 
Deletion 
collection 
Table 2.2: Plasmids 
Plasmids Number Vector Backbone Resistance Reference 
pPM47 (UPR-RFP 
CEN/ARS URA3) 
Addgene 
plasmid # 20132 
pRS316 URA 28 
pAMS366 (4X 
CDRE-lacZ 
URA3) 
_ pAMS366 URA 29 
pRS316 BCK1-20 – pRS316 URA 30 
pRS416 GPD ATCC 87360 pRS416 URA 31 
 
2.2.2 Spotting and Liquid Growth Assays 
Cell growth was assessed by both spot assay and liquid culture as previously described by 
Duennwald (2013). Briefly, spotting assays were performed with yeast cells that were 
cultured overnight in selective media with 2% glucose as the sole carbon source. Cells 
were then diluted to equivalent concentrations of OD600 0.2 and were spotted in 4 
sequential five-fold dilutions. Equal spotting was controlled by simultaneously spotting 
cells using a multi-channel ultra-high-performance pipette (VWR International). Cells 
were grown on selective plates at 30C for 2 days and imaged using a Geldoc system 
(Bio-RAD). For liquid cultures cells were diluted to OD600 0.15 and incubated at 30C. 
OD600 was measured every 15 mins using a BioscreenC plate reader (Growth curves 
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USA) for 24 h. Growth curves were generated and the area under the curve was 
calculated for biological replicates. Statistical significance was determined using a two-
tailed student T-test and GraphPad (Prism). 
2.2.3 Yeast Transformation 
Yeast transformations were performed using the lithium acetate transformation protocol 
as previously described32. Briefly, 1 mL of OD600 = 1, overnight cultures were pelleted at 
3000 xg for 1 min. Cells were aspirated and washed with 1.5 mL sterile 0.1 M LiAc in 
TE buffer. Cells were then pelleted and resuspended in 285 L sterile 50% PEG 4000 in 
0.1M LiAc, 2.5 L plasmid, and 10 L boiled salmon sperm DNA, and incubated at 
30C for 45 mins. After that, 43 L of sterile DMSO was added and cells were heat 
shocked for 15 min at 42C before being plated on amino acid selection plates. 
2.2.4 Drugs 
Stock solutions of tunicamycin (5 g mL-1 in DMSO; Amresco), calcofluor white (30 mg 
mL-1 in H2O; Sigma Aldrich), rapamycin (1 mg ml-1 in DMSO;  Fisher Bioreagents), 
sorbitol (3 M in H2O; Fisher Bioreagents), and fluorescent brightener 28 (Calcofluor 
white stain; 25M; Sigma Aldrich) were used at the indicated concentrations.  
2.2.5 Stress Condition Experiments 
In all the experiments, yeast cultures were grown to log phase (OD600 ~0.3) before being 
exposed to different stress conditions. Endoplasmic reticulum stress was achieved by 
adding 0.5 g mL-1, 1.0 g mL-1, or 2.5 g mL-1 tunicamycin (Amresco) or by inositol 
withdrawal. For inositol depletion experiments, cells were washed twice in SC media 
(YNB-Inositol; Sunrise Science) and then resuspended into pre-warmed SC media 
lacking inositol. Cell wall stress was achieved by adding 5-20 g mL-1 calcofluor white. 
Sorbitol rescue assays were facilitated by adding 1 M sorbitol to the media. 
2.2.6 Quantitative RT-PCR 
RNA extraction was performed using the MasterPure Yeast RNA Purification Kit 
(Epicentre). cDNA was synthesized using the RevertAid H Minus First Strand cDNA 
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Synthesis Kit (Thermoscientific). The cDNA preparations were used as templates for 
amplification using SsoAdvancedTm Universal SYBR ® Green Supermix (Bio-Rad). The 
primers used are listed in Table 2.3. The relative expression levels were calculated using 
the comparative Ct method with U3 as a reference gene.  
Table 2.3: Primers 
Gene Forward Primer Reverse Primer 
U3 CCCAGAGTGAGAAACCGAAA AGGATGGGTCAAGATCATCG 
KAR2 CCGGTGAAGAAGGTGTCGAA CATGGCTCTTTCACCCTCGT 
RPL30 ATCATTGCCGCTAACACTCC CCGACAGCAGTACCCAATTC 
INO1 TCGACGTACAAGGACAACGA GGCCACTAAAGTGGAGCCAT 
HAC1 ACGACGCTTTTGTTGCTTCT TCTTCGGTTGAAGTAGCACAC 
PRM5 GACATAAGGAAACCCGCAAA CCAGCATGTGCTCGAGATAA 
FKS2 CTGAGCGCCGTATTTCATTT CGGGTGTAATTGCTTCAGGT 
FKS1 TTTGGTTCCAATTGGGTGTT CCGCAAACACTTCGAACATA 
FIT1 GTGAACGTGCTCCTGTCTCA GTTCACCCTCACCAGTCCAT 
FIT2 GACACCGCTGACCCTATCAT GATGATTCGACGGCTTGAGT 
FIT3 TATCACTGCCACCAAGAACG AATTCAGCGGTGCTAGAGGA 
 
2.2.7 Fluorescence Microscopy 
TOR1 and TOR1L2134M cells expressing a UPR-mcherry fluorescent reporter were grown 
to mid-log phase before being treated with 2.5 g mL-1 tunicamycin (Amresco) or 
inositol withdrawal for 3 h. Cells were diluted 10X, transferred to a 96 well plate, and 
imaged at room temperature.  Fluorescence microscopy was performed using the 
Cytation 5 Cell Imaging Multi-Mode Reader (BioTek); the 20X objective lens and Texas 
Red Filter cube (586  647-1  nm) were used. Images were analyzed using ImageJ software 
(https://imagej.nih.gov/ij/). Violin plots presented in Figure 2.2D were generated using 
the PlotsOfData software 33. 
2.2.8 HAC1 Splicing Assay 
Cells were cultured to mid-log phase before being treated with either 1.0 g/mL 
tunicamycin (Amresco) or inositol withdrawal for 2 h. RNA extraction was performed 
using the MasterPure Yeast RNA Purification Kit (Epicentre). cDNA was synthesized 
from the extracted RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit 
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(Thermoscientific). The cDNA preparations were then used as templates for RT-PCR 
with HAC1 primers (listed in Table 4). The resulting reaction product was separated by 
electrophoresis on an agarose gel and bands were visualized using a Geldoc system (Bio-
Rad).  
2.2.9 β-galactosidase Assay 
TOR1 and TOR1L2134M  yeast strains transformed with plasmids carrying the CDRE-LacZ 
reporter were assayed as previously described 34. Briefly, cells were grown to log phase 
in selective SC media, harvested by centrifugation, then cultured in SC media containing 
the indicated concentrations of stressors or CaCl2. After incubation at 30C for 2 h, cells 
were harvested by centrifugation and resuspended in lacZ buffer. To measure β-
galactosidase activity, 50 L cell lysate was mixed with 950 L lacZ buffer containing 
2.7 L β-mercaptoethanol, 1 drop 0.1% SDS, 2 drops CHCl3 and incubated at 30C for 
15 min. The reaction was started by adding 100 L ONPG (4 mg mL-1) and incubated at 
30C till the colour changed to yellow. The reaction was stopped by adding 300 L of 1 
M Na2CO3. β-galactosidase activity was determined at 420 nm absorbance using a plate 
reader, normalizing data to cell density. 
2.2.10 Protein Extraction and Western Blot 
Cells were lysed using alkaline lysis with 0.1 M NaOH 35 and proteins were extracted 
into 4x Laemmli sample buffer containing 100 mM DTT. Protein samples were separated 
using SDS-PAGE (BioRad Mini-PROTEAN TGX Pre-Cast gels, 4-15%) and transferred 
to nitrocellulose membranes using the BioRad Trans-Blot® TurboTM RTA Transfer Kit. 
Membranes were blocked with 5%  fat free milk for 30 mins, before probing with P-S6 
Ribosomal Protein S235 236-1 Rabbit Ab (Cell Signaling Technology) or anti-PGK1 
(Invitrogen) overnight at 4C. Membranes were then incubated with the Alexa Fluor 488 
goat anti-rabbit for 1 hr. Membranes were imaged using a BioRad infrared imager 
(BioRad). 
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2.2.11 Calcofluor White Stain Microscopy and Flow Cytometry 
TOR1 and TOR1L2134M cells were grown in triplicate to mid-log phase in YPD media, 
before being treated with Fluorescent Brightener 28 (Sigma-Adlrich) to a final 
concentration of 25 M. Cells were grown for 20 min at 30C with continuous shaking 
before they were pelleted and washed in SC media. Cells were diluted 10x in growth 
media and plated in Lab-Tek (Thermo Inc.) imaging chambers and processed for 
fluorescence microscopy. Images were acquired using a Zeiss AxioVert A1 wide filed 
fluorescence microscopy equipped with a 63X NA 1.4 Plan Apopchromat objective, 359 
nm excitation 461 nm-1 emission (DAPI) long pass filter and an AxioCam ICm1 R1 CCD 
camera (Carl Zeiss inc.). Images were analyzed using ImageJ software. For flow 
cytometric analysis, cells were cultured in appropriate media and processed for flow 
cytometry using a BD Bioscience FACS Celesta flow cytometer equipped with a 405 nm 
Violet laser. Data was analyzed using the BD FACS Diva Software. All conditions were 
performed in triplicate, 20 000 cells were analyzed, and mean fluorescence intensities 
were calculated. No gates were applied.  
2.2.12 Microarray Analysis 
TOR1 and TOR1L2134M yeast cultures were grown to log phase (OD600 ~0.3) before being 
treated with tunicamycin (2.5 μg/mL). RNA was extracted from two independent cultures 
(n=2) and quality was assessed with Bioanalyzer as previously described 36. Microarray 
analysis was conducted with the GeneChip® Yeast Genome 2.0 Array (Affymetrix, Santa 
Clara, California, USA). Briefly, biotinylated complimentary RNA (cRNA) was prepared 
from 100 ng of total RNA as per the GeneChip 3’ IVT PLUS Reagent Kit manual 
(ThermoFisher Scientific, Waltham, MA). Data was analyzed using the Transcriptome 
Analysis Console (TAC) software (Affymetrix) by filtering for genes that showed a two-
fold change in expression with a p-value of 0.05 using sacCer3 as a reference genome. 
Gene lists were created using the gene ontology term finder on the Saccharomyces 
genome database (https://www.yeastgenome.org/). All microarray data were submitted to 
the GEO database as series GSE129200. 
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2.3 Results and Discussion 
2.3.1 Hyperactive TOR1L2134M sensitizes cells to ER stress 
Previous studies show that the TOR pathway links nutrient status to cell growth and 
ribosome biogenesis, under conditions of protein misfolding stress 37–39. However, it 
remains unclear to what extent modulation of TORC1 signaling is required for adaptation 
to ER stress. Thus, we sought to investigate the effects of TORC1 signaling on the 
sensitivity to ER stress. 
The phosphorylation of the ribosomal protein, RPS6, is regulated in a TORC1-dependent 
manner and serves as a valid readout for TORC1 activity in vivo 40,41. Previous reports 
indicate that under conditions of oxidative- and proteotoxic stress, RPS6 phosphorylation 
is dramatically reduced 42,43. Therefore, we sought to investigate whether ER stress 
downregulates RPS6 phosphorylation in cells with hyperactive TORC1 signaling (Fig. 
2.1A). As such, cells expressing either WT TOR1 or hyperactive TOR1L2134M were treated 
with the canonical ER stress inducer, tunicamycin (Tm; Fig. 2.1B). Tm is a potent 
inducer of the UPR as it inhibits N-glycosylation of proteins, prevents proper protein 
folding, and thereby causes an accumulation of misfolded proteins in the ER 44. While the 
addition of Tm (2.5 ug/mL) significantly decreased RPS6 phosphorylation in cells 
expressing WT TOR1, there was no significant difference in cells expressing hyperactive 
TOR1L2134M (Fig. 2.1B-C). Rapamycin, an inhibitor of TORC1, was used as a positive 
control, for Sch9 downregulation. Combined with previous studies showing that 
phosphorylation of Sch9, another TORC1 effector, is decreased during Tm treatment 45, 
our results suggest that TORC1 deactivation plays an important role in ER stress 
tolerance.  As such, we then sought to determine how impacting proper TORC1 signaling 
affects the cell’s response to ER stressors. 
First, we assessed cell growth in the presence of both Tm and the TORC1 inhibitor, 
rapamycin (Fig. 2.1D). We found that rapamycin treatment exacerbates the growth defect 
caused by Tm-induced ER stress (Fig. 2.1D). Similarly, cells expressing a rapamycin-
resistant hyperactive TOR1L2134M 24 displayed an increased growth defect upon Tm stress 
(Fig. 2.1D). To investigate the effects of hyperactive TOR1 on a more physiologically 
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relevant ER stressor, cells were exposed to conditions of inositol withdrawal. While it is 
unclear how exactly inositol deprivation triggers UPR activation, some studies have 
postulated that it triggers the UPR by either changing the lipid composition of the ER 
membrane 46–48 or by impairing membrane trafficking 49,50. In contrast to cells expressing 
WT TOR1, cells expressing the hyperactive allele were inositol auxotrophs (Fig. 2.1D). 
Increased ER stress sensitivity of TOR1L2134M was confirmed using liquid growth assays 
(Fig. 2,1E-F). As expected, compared to cells expressing WT TOR1, cells expressing 
hyperactive TOR1L2134M had a significant growth defect following treatment with Tm 
(Fig. 1E) or inositol withdrawal (Fig. 2.1F). Taken together, our results indicate that 
defective TORC1 signaling increases sensitivity to canonical ER stressors. Both 
phenotypes can be linked to a defective response to ER stress. 
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(A) Representative schematic of the downstream targets of TORC1 kinase activity. (B) 
Western blot analysis of RPS6 phosphorylation following treatment with tunicamycin 
(Tm; 2.5 μg/mL) or rapamycin (Rap; 200 ng/mL). Pgk1 was used as a loading control. 
(C) Quantification of (B). Sch9 phosphorylation is not attenuated in hyperactive 
TOR1L2134M cells following treatment with tunicamycin (n=4; ± SD). (D) Cell growth of 
WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on YPD plates 
supplemented with rapamycin (Rap; 10 ng/mL), tunicamycin (Tm; 1.0 μg/mL), both Rap 
and Tm, or SC plates supplemented without inositol (+/- Inositol). Cells expressing 
hyperactive TOR1L2134M were more resistant to rapamycin treatment and more sensitive to 
tunicamycin stress and inositol withdrawal. (E) Liquid growth assays of yeast cells 
expressing WT TOR1 and TOR1L2134M were used to further assess sensitivity to 
tunicamycin stress (Tm; 1.0 μg/mL) and (F) inositol withdrawal (-Ino). Data is quantified 
as area under the curve (AUC; *p < 0.01; mean ± SD; n=3).  
  
 
 
 
 
 
 
 
Figure 2.1: Cells expressing hyperactive TOR1L2134M are more sensitive to ER stress 
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2.3.2 Cells expressing hyperactive TOR1L2134M have a functional 
UPR 
Having shown that cells expressing hyperactive TOR1L2134M are more sensitive to ER 
stress, we next sought to examine whether this increased sensitivity was due to defects in 
the ability to activate the UPR. As previously described, under conditions of ER stress, 
the ER protein folding sensor, Ire1, splices HAC1 mRNA to produce an active 
transcription factor 4.  We therefore assessed the ability of Ire1 to splice HAC1 mRNA 
using RT-PCR (Fig. 2.2A-B). Surprisingly, inositol withdrawal induced HAC1 splicing in 
both WT TOR1 and hyperactive TOR1L2134M mutants (Fig. 2.2A, arrow). Additionally, 
after 1 hr of treatment with Tm, cells expressing hyperactive TOR1L2134M spliced HAC1 
mRNA, and this response was still evident after 2 hrs of induction, as indicated by a 
smaller fragment in the agarose gel (Fig. 2.2B, arrow). As a whole, these results indicate 
that increased ER sensitivity of cells expressing hyperactive TOR1L2134M is not due to 
impaired functionality of the UPR.  
Spliced HAC1 mRNA is translated into an active transcription factor, which then 
translocates to the nucleus where it binds to unfolded protein response element (UPRE) 
sequences in gene promoters44. In response to ER stress, Hac1 alone activates over 400 
UPR target genes, including ER chaperones, genes that mediate membrane expansion, 
and genes involved in ribosome biogenesis 1,51,52. As such, increased sensitivity to ER 
stress may be due to an inability to transcriptionally activate the UPR.  We tested this 
possibility by transforming a UPRE-mcherry fluorescent reporter 28 into cells expressing 
TOR1 and TOR1L2134M and assessing UPR activation with fluorescence microscopy (Fig. 
2.2C-D). Surprisingly, there was no significant difference between cells expressing TOR1 
and hyperactive TOR1L2134M in their ability to activate the UPR under conditions of Tm 
stress and inositol withdrawal. Additionally, we quantitatively assessed the mRNA levels 
of the yeast resident chaperone and canonical UPR target gene, KAR2, using qRT-PCR 
(Fig. 2.3A). In line with our previous data, hyperactive TOR1L2134M was able to increase 
the expression of KAR2, following treatment with Tm and inositol withdrawal. Taken 
together, these results suggest that the increased sensitivity of cells expressing 
TOR1L2134M to ER stress is unlikely to be due to impaired UPR activation. 
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Additionally, actively dividing yeast allocate up to 85% of their transcriptional activity to 
ribosome biogenesis 53; however, under conditions of ER stress, there is a downregulation 
in the expression of ribosome genes in order to increase the expression of UPR target 
genes 54,55. As such, we employed qRT-PCR to assess the expression of RPL30, a gene 
involved in ribosome biogenesis (Fig. 2.3B). Cells expressing hyperactive TOR1L2134M 
significantly downregulated expression of RPL30 (Fig. 2.3B). This is probably due to the 
fact that multiple pathways regulate ribosome biogenesis. For example, PKA deactivation 
during ER stress is also responsible for repressing transcription of ribosomal protein 
genes 12. Furthermore, depleting inositol triggers the ER sensor, Ire1, which induces 
transcription of the inositol biosynthetic gene, INO1 8,56. Therefore, we investigated 
whether the inositol auxotrophy of cells expressing TOR1L2134M was due to the inability to 
synthesize INO1. Cells expressing TOR1 and TOR1L2134M were treated with inositol 
withdrawal and qRT-PCR was conducted to assess the expression of INO1 and RPL30 
(Fig. 2.3C-D). Interestingly, hyperactive TOR1L2134M impaired the transcription of INO1 
(Fig. 2.3C) but did not impair ribosome biogenesis (Fig. 2.3D). Taken together, these 
results suggest that under conditions of ER stress, cells expressing hyperactive 
TOR1L2134M are defective in regulating INO1 transcription. 
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(A) Treatment with ER stressors induces HAC1 mRNA splicing. WT TOR1 and 
hyperactive TOR1L2134M mutants were either untreated (Ctrl.), treated with inositol 
withdrawal (-Ino), or (B) treated with tunicamycin (Tm; 1.0 μg/mL) for up to 2 hrs. RT-
PCR was conducted using HAC1 primers. Arrows indicate Ire1 mediated HAC1 splicing. 
(C) Representative fluorescence microscopy images of WT TOR1 and TOR1L2134M cells 
expressing UPR-mcherry fluorescent reporters, following treatment with tunicamycin 
(Tm; 1.0 μg/mL) and inositol withdrawal (-Ino) for 2 hours. (D) Quantification of (C). 
Hyperactive TOR1L2134M promotes expression of UPR-induced genes in conditions of 
tunicamycin stress and inositol withdrawal (n=50; *p < 0.0001). 
 
 
 
 
 
 
 
Figure 2.2: The UPR is not impaired in yeast cells expressing hyperactive 
TOR1L2134M 
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(A) Representative fluorescence microscopy images of WT TOR1 and TOR1L2134M cells 
expressing UPR-mcherry fluorescent reporters, following treatment with tunicamycin 
(Tm; 1.0 μg/mL) for 2 hours. (B) Quantification of (A). Both WT TOR1 and hyperactive 
TOR1L2134M have significantly increased UPR-mcherry fluorescence following treatment 
with tunicamycin (n=50; *p<0.05). (C) Fluorescence microscopy of WT TOR1 and 
TOR1L2134M cells expressing UPR-mcherry fluorescent reporters, following treatment 
with inositol withdrawal (- ino). (D) Quantification of (C). Hyperactive TOR1L2134M 
promotes expression of UPR-induced genes in conditions of inositol withdrawal (n=50; 
*p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Hyperactive TOR1L2134M can transcriptionally activate the UPR, but 
has impaired inositol synthesis 
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2.3.3 Defects in cell wall integrity underlie TOR1L2134M sensitivity to 
ER stress 
Despite having a functional UPR, our studies show that cells expressing hyperactive 
TOR1L2134M have increased sensitivity to canonical ER stressors. Therefore, to assess how 
ER stress alters the transcriptome in hyperactive TOR1L2134M mutants, we treated two 
independent cultures of WT TOR1 and hyperactive TOR1L2134M cells with Tm and used 
microarray analysis to uncover genes that were differentially expressed in hyperactive 
TOR1L2134M cells (Fig. 2.4A-D). Data was analyzed by filtering for genes that showed a 
two-fold change in expression with a p value < 0.05.  The transcripts of the genes that 
were differentially downregulated (Fig. 2.4C) and upregulated (Fig. 2.4D) were 
categorized based on their cellular components using the yeast SGD GO term finder. 
Interestingly, among the genes that were upregulated, a large majority encoded proteins 
that localized to the cell periphery and plasma membrane (Fig. 2.4D). Of note, genes 
encoding three cell wall incorporated mannoproteins, FIT1, FIT2, and FIT3 were 
upregulated in hyperactive TOR1L2134M cells (Fig. 2.4D). Fit proteins are involved in iron 
uptake 57. Validation with qRT-PCR revealed that hyperactive TOR1L2134M cells had 
significantly higher steady-state levels of FIT1, FIT2, and FIT3, compared to cells 
expressing WT TOR1 (Fig. 2.4E-G). Interestingly, FIT genes are also upregulated in cells 
carrying deletions in genes encoding the phosphatases PTC1 and PTC6 that displayed 
compromised TORC1 signaling 58.   Additionally, the expression of both FIT2 and FIT3 
was significantly higher compared to WT TOR1 cells following treatment with Tm (Fig. 
2.4F-G). Interestingly, increased mannoprotein levels is observed in cells with 
compromised cell wall 59. Taken together, these results suggest that hyperactive 
TOR1L2134M alters the cell wall composition of yeast cells.  
ER stress tolerance in yeast depends on the activation of the cell wall integrity pathway, 
which is, in part, regulated by TORC1 60–64. Additionally, cells with defects in cell wall 
integrity exhibit inositol auxotrophy 65. As such, we investigated whether the increased 
sensitivity of cells expressing hyperactive TOR1L2134M was due to defects in cell wall 
integrity. A general approach to assess whether a specific phenotype is due to a cell wall 
defect is to test the remediating effects of the cell wall stabilizer sorbitol 66. Interestingly, 
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supplementing with sorbitol rescued the toxicity caused by Tm stress in hyperactive 
TOR1L2134M mutants (Fig. 2.5A), suggesting that these cells have a defective cell wall. To 
further examine cell wall composition, cells expressing TOR1 and TOR1L2134M were 
treated with the cell wall antagonist, calcofluor white (CFW) and liquid growth assays 
were assessed (Fig. 2.5B). In line with our previous results, cells expressing hyperactive 
TOR1L2134M were significantly more sensitive to CFW than cells expressing WT TOR1 
(Fig. 2.5B). Previous literature indicates that due to increased activation of cell wall stress 
responses, yeast strains with defects in cell wall integrity have a greater deposition of 
chitin in their cell wall and become more sensitive to the CFW 67. Therefore, cells 
expressing TOR1 and TOR1L2134M were stained with CFW and chitin staining was 
analyzed using fluorescence microscopy and flow cytometry (Fig. 2.5C). Compared to 
WT TOR1 cells, cells expressing hyperactive TOR1L2134M appeared more clustered and 
displayed significantly more chitin content (Fig. 2.5C). Taken together, our data suggests 
that the increased sensitivity of hyperactive TOR1L2134M mutants can be traced back to 
defects in cell wall integrity.  
Consistent with a defect in cell wall biogenesis, loss of function of any kinase 
downstream of the canonical MAPK cell wall integrity pathway (CWI) results in growth 
defects at elevated temperatures 68–71.  Therefore, we investigated whether the increased 
sensitivity of hyperactive TOR1L2134M to ER stress could be attributed to defects in the 
canonical CWI pathway. Surprisingly, compared to WT TOR1 cells, cells expressing 
hyperactive TOR1L2134M showed no growth defect at elevated temperatures (Fig. 2.5D).  
To further investigate whether the CWI pathway was impaired, we assessed the effects of 
constitutive activation of the CWI pathway by transforming a hyperactive BCK1-20 allele 
into WT TOR1 and hyperactive TOR1L2134M cells (Fig. 2.5E). Interestingly, BCK1-20 
overexpression equally rescued Tm toxicity in both WT TOR1 and hyperactive 
TOR1L2134M cells (Fig. 2.5E), with TOR1L2134M cells still displaying increased sensitivity 
compared to wild-type. These results indicate that other regulators of the cell wall 
composition downstream of Bck1 may be defective in the mutant cells.   
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(A) Microarray analysis of genes differentially expressed in yeast cells expressing WT 
TOR1 or hyperactive TOR1L2134M, following treatment with tunicamycin (Tm; 2.5 
μg/mL). Arrows indicate cell wall genes that are differentially expressed in cells 
expressing hyperactive TOR1L2134M. (B) Microarray analysis of genes differentially 
expressed in TOR1 and TOR1L2134M control cells compared to TOR1 and TOR1L2134M cells 
treated with tunicamycin (Tm; 2.5 μg/mL). (C) Genes downregulated two-fold in 
hyperactive TOR1L2134M cells in response to tunicamycin stress (Tm; 2.5 μg/mL). (D) 
Genes upregulated two-fold in hyperactive TOR1L2134M cells in response to tunicamycin 
stress. Gene ontology lists were generated with the gene ontology term finder on the 
Saccharomyces genome database. Numerous cell wall genes are differentially expressed 
in hyperactive TOR1L2134M cells compared to cells expressing WT TOR1. (E) qRT-PCR 
was used to validate the microarray analysis and assess expression of mannoprotein genes 
FIT1, (F) FIT2, and (G) FIT3 following treatment with tunicamycin (Tm; 2.5 μg/mL; 
n=3; ± SD). 
 
 
 
 
 
 
 
Figure 2.4: ER stress induces a change in the cell wall composition of cells 
expressing hyperactive TOR1L2134M 
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(A) Cell growth of WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on 
YPD plates supplemented with various concentrations of tunicamycin (Tm), sorbitol (1 
M), or both tunicamycin and sorbitol. Sorbitol rescues tunicamycin toxicity caused by 
hyperactive TOR1L2134M. (B) Liquid growth assay of TOR1 and TOR1L2134M cells 
following treatment with calcofluor white (CFW; 20 μg/mL). Data was quantified by 
measuring area under the curve (AUC; n=3; *p < 0.001; mean ± SD). C) Representative 
fluorescence microscopy images of cells expressing WT TOR1 and hyperactive 
TOR1L2134M, following treatment with calcofluor white (CFW; 20 μg/mL). Cells 
expressing hyperactive TOR1L2134M are aggregated and have increased fluorescence, 
corresponding to an increase in chitin synthesis (Left panel). Flow cytometric analysis of 
cells treated with calcofluor white (CFW; 2.5 μg/mL). Cells expressing hyperactive 
TOR1L2134M have significantly higher mean fluorescence intensity compared to WT TOR 
cells (right panel; n = 3; mean ± SD). (D) Growth of WT TOR1 and TOR1L2134M cells in 
response to elevated temperature was assessed by serial dilution on YPD plates. There 
was no growth defect caused by hyperactive TOR1L2134M. (E) Cell growth of WT TOR1 
and TOR1L2134M transformed with either an empty vector or BCK1-20 was assessed by 
serial dilution on SC-ura plates supplemented with various concentrations of tunicamycin 
(Tm). 
 
 
 
 
 
 
Figure 2.5: Increased sensitivity of hyperactive TOR1L2134M, in response to ER 
stress, is due to defects in cell wall integrity 
69 
 
2.3.4 Hyperactive TOR1L2134M cells have defects in glucan 
synthase expression and are more sensitive to the 
antifungal, caspofungin 
Within the host organism, pathogenic fungi face numerous environmental stressors such 
as low nutrient availability and changes in pH and temperature 72,73. As such, the fungal 
cell wall acts as the first line of defense, providing a rigid cellular boundary to withstand 
internal turgor pressure and extracellular stresses 74. Proper cell wall architecture requires 
three major components: β-1-3-glucan, chitin, and mannoproteins– all of which come 
together to form a large macromolecular complex 74,75. Our results indicate that cells 
expressing hyperactive TOR1L2134M increase expression of mannoprotein genes as well as 
chitin aggregation, both of which are phenotypes associated with impaired  β-1-3-glucan 
synthesis 76–78. To test this possibility, we used qRT-PCR to assess the expression of the 
β-1-3-glucan synthase genes, FKS2 and FKS1 (Fig. 2.6A-B). Interestingly, expression of 
both FKS2 (Fig. 2.6A) and FKS1 (Fig. 2.6B) was significantly decreased in hyperactive 
TOR1L2134M cells, following treatment with Tm. Given that Ca2+/ calcineurin and CWI 
signaling converge to mediate FKS1/2 expression 77,79, we differentially assessed the 
activity of these pathways. There was no evidence that the Ca2+/ calcineurin pathway was 
impaired in presence of Tm-induced ER stress (Fig. 2.7). Additionally, we examined the 
activation of Rlm1 – another transcription factor regulating cell wall integrity– by 
assessing the expression of its downstream target, PRM5 (Fig. 2.6C). We found that 
activation of the Rlm1 branch was not impaired in hyperactive TOR1L2134M cells (Fig. 
2.6C). Taken together, our results support the notion that defects in the cell wall 
architecture of hyperactive TOR1L2134M mutants may be due to dysregulation of other 
regulators of the cell wall integrity such as the SWI4/6-SBF complex. More 
comprehensive studies will be required to uncover the complex role of TORC1 in the 
control of cell wall biogenesis and maintenance.  
Given that the cell wall is essential for fungal survival and its composition is unique to 
the fungal organism, this structure acts as an ideal target for antifungal drugs 80. Notably, 
echinocandins represent the first class of antifungal drugs that specifically target the 
fungal cell wall 81,82. In particular, the echinocandin caspofungin acts as a fungicide by 
noncompetitively inhibiting the β-1-3-glucan synthases, Fks1 and Fks2, thereby blocking 
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cell wall synthesis 83. Since our results indicate that hyperactive TOR1L2134M impairs 
FKS2 and FKS1 synthesis, we investigated whether this defect sensitizes cells to the 
antifungal, caspofungin (Fig. 2.6D). Indeed, cells expressing hyperactive TOR1L2134M 
exhibited a growth defect as compared to WT TOR1 cells, and this defect was further 
exacerbated with increasing concentrations of caspofungin (Fig. 2.6D). To further 
elucidate the connection between ER stress signaling and sensitivity to antifungal drugs, 
we examined the growth of ire1Δ cells following treatment with caspofungin (Fig. 2.6E). 
Compared to wild-type strains, ire1Δ showed hypersensitivity to caspofungin, suggesting 
that a functional ER stress response is required for resistance to this antifungal drug (Fig. 
2.6E). Similarly, UPR-deficient strains of pathological fungi such as C. 
neoformans and A. fumigatus show decreased virulence in animal models 84–87. 
Interestingly, deletion of MDS3 in Candida albicans leads to TORC1 hyperactivation 
resulting in filamentation defects, supporting a negative role for TORC1 hyperactivation 
in pathogenicity 88. Conversely, reduced TORC1 signaling in oma1Δ strains resulted in 
attenuated TORC1 signaling and increased virulence in Candida albicans 89. Thus, the 
amplitude of TORC1 signaling emerges as an important determinant of the capacity of C. 
albicans cells to withstand stress such as oxidative stress 90 and perhaps ER stress, thus 
impacting its virulence and pathogenicity.  
While initially described as distinct pathways, our research points to a functional 
interaction between the UPR, TORC1, and CWI signaling pathways. Here, we use a 
hyperactive variant of TOR1 to present a novel mechanism of ER stress regulation by 
TORC1 signaling. We show that attenuation of TORC1 signaling is required for 
adaptation to ER stress, and that hyperactive TORC1 signaling results in compromised 
cell wall architecture. Taken together, we propose that hyperactivation of TORC1 
signaling alters cell wall composition, sensitizing cells to ER stress causing agents such 
as antifungal drugs. 
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(A) Cells expressing WT TOR1 or hyperactive TOR1L2134M were treated with tunicamycin 
(Tm; 2.5 μg/mL) for 2 hrs. Tm induced a significant decrease in the expression of glucan 
synthase genes FKS2 and (B) FKS1 as measured by qRT-PCR (n=3; ± SD). (C) qRT-
PCR was also used to assess the expression of the Rlm1 target, PRM5 (n=3; ± SD). (D) 
Cell growth of WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on YPD 
plates supplemented with various concentrations of the antifungal drug, caspofungin. 
Compared to WT TOR1, hyperactive TOR1L2134M cells have impaired growth. (E) Growth 
of wild-type cells and Ire1Δ cells was assessed by serial dilutions on YPD plates 
supplemented with various concentrations of the antifungal drug, caspofungin. Ire1Δ 
cells have increased sensitivity to caspofungin. 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Cell wall perturbations in hyperactive TOR1L2134M cells can be traced 
back to defects in glucan synthase activity 
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(A) β-galactosidase activity (measured in LacZ units) was used to assess expression of 
calcineurin dependent response element (CDRE) following treatment with CaCl2 (1 M), 
tunicamycin (Tm; 1.0 μg/mL), or inositol withdrawal (-ino; n =6). (B) Growth of cells 
expressing WT TOR1 or hyperactive TOR1L2134M was assessed by liquid growth assay 
following treatment with 0.05 M CaCl2, (C) 0.08 M CaCl2, (D) 0.1 M CaCl2, or (E) 0. 2 
M CaCl2. The area under the curve (AUC) was quantified for each replicate (n=3). There 
was no significant difference (p > 0.05) between the two yeast strains.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: The Ca2+/calcineurin pathway is not impaired in hyperactive 
TOR1L2134M cells 
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2.3.5 Conclusion 
The high prevalence of pathogenic fungal infections, coupled with the emergence of new 
fungal pathogens, has rapidly brought these diseases to the forefront of global health 
problem. Of particular concern are the millions of people worldwide that will contract life-
threating invasive fungal infections (IFI) – diseases with a mortality rate which exceeds 
50%, even with the availability of antifungal treatments 91,92. As a whole, the aetiological 
agents responsible for more than 90% of IFI-related deaths fall largely within four genera 
of fungi: Cryptococcus, Candida, Aspergillus, and Pneumocytis 91,93. While antifungal 
treatments have advanced over the last decade, patient outcomes have not substantially 
improved 94. These shortcomings are largely attributed to the evolutionary similarity 
between fungi and humans, which limits the scope of drug development against fungal 
specific targets. As such, there is a pressing need to understand the unique cellular 
mechanisms that govern fungal viability. Given that S. cerevisiae is evolutionarily related 
to a number of pathogenic fungi, and in particular to the Candida species 95, most genes 
from S. cerevisiae are highly conserved in pathogenic fungal strains. Among the shared 
genomic features includes similar mechanisms for cell wall homeostasis 96–98 and activation 
of stress responses 99. Here we show that hyperactivation of TORC1 signaling sensitizes 
yeast cells to both ER stress and cell wall stressors by compromising cell wall integrity. 
Therefore, targeting TORC1 signaling and ER stress pathways may be useful in developing 
novel targets for antifungal drugs. 
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Chapter 3  
3 General Overview 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
3.1 Discussion, Future Directions and Conclusions 
The UPR is a major stress response pathway that is activated in response to an 
accumulation of misfolded proteins in the ER1,2. To mediate protein folding homeostasis, 
the UPR increases the protein folding capacity and decreases the protein folding load in 
the ER. While initially thought to function in isolation during ER stress, recent research 
indicates that the UPR is finetuned by signaling pathways from other cellular 
compartments. For instance, in S.cereviasie, both the Slt2 cell wall integrity pathway and 
the Hog1 hyperosmotic pathway have been implicated in the response to ER stress3–5. 
Furthermore, the transcriptional response to ER stress includes the induction of the 
general stress response (GSR) which is governed by PKA signaling and regulated by the 
Msn2/4 transcription factors6,7. Aside from its role in mediating the GSR, deactivation of 
PKA signaling during ER stress also decreases the protein folding load in the ER, namely 
by repressing ribosome biogenesis8,9. Given that downregulation of ribosome 
biosynthesis is a consequence of ER stress, we rationalized that exploring pathways 
involved in ribosomal homeostasis would allow us to elucidate key players that interface 
with the UPR to regulate ER homeostasis. Interestingly, in S. cerevisiae, the target of 
rapamycin complex 1 (TORC1) signaling pathway couples cell nutrient status and stress 
signaling to regulate ribosome biogenesis10,11. As such, elucidating the interplay between 
cell growth regulators, such as PKA and TORC1 signaling, and stress response pathways 
such as the UPR, is crucial in facilitating an understanding of the cellular response to 
proteotoxic stress.  
Here we show that attenuating TORC1 signaling is required for adaptation to ER stress; 
however, what remains unclear are the upstream pathways responsible for propagating 
this signal to TORC1. Attenuation of TORC1 signaling during ER stress may be 
regulated by alterations in membrane composition12,13. In this regard, intracellular 
signaling pathways could be activated in response to changes in the physical properties of 
the plasma membrane such as fluidity or thickness14. More specifically, the impaired 
transport of membrane proteins and lipids from the secretory pathway, during ER stress, 
may trigger a signal to repress ribosome biogenesis in order to relieve secretory stress. Of 
particular interest are sphingolipids, molecules that not only function as second 
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messengers, but are also trafficked through the secretory pathway and delivered as 
integral components of the plasma membrane14–16. Recent research has proposed that 
sphingolipid/Pkh1/2-TORC1/Sch9 signaling may play a role in the transcriptional 
repression of ribosomal proteins, following tunicamycin-induced ER stress17,18. 
Nevertheless, further work is required to identify key sensors that impinge on TORC1 to 
attenuate downstream signaling during ER stress. 
To determine how impacting proper TORC1 signaling affects the cell’s response to ER 
stressors, we used a constitutive allele of the TOR1 kinase, TOR1L2134M. We show that 
constitutive activation of TORC1 prevents its downregulation and confers increased 
sensitivity to ER stressors such as Tm and inositol withdrawal, independently of the 
UPR. We propose that TORC1 hyperactivation results in cell wall remodeling and 
impaired SWI4/6 signaling, and thereby sensitizes cells to ER stressors and cell wall 
antagonists, including the antifungal caspofungin (Fig. 3.1). This observation is 
particularly relevant to the field of pathogenic fungal infections, where there is a pressing 
need to identify novel targets for antifungal drugs. Interestingly, the components of the 
ER stress response pathways have been studied extensively  in a number of fungal 
pathogens including the Asperigullus species19–21, Cryptoccous neoformans22,23, 
Cryptococcus gattii24, Candida albicans25, and Candida galbrata26, with the basic aspects 
of the Ire1-mediated response being highly conserved amongst the species. However, 
while the ER stress response pathways play a redundant role in the virulence of most 
pathogenic species, there are some notable differences between species, particularly in 
Candida glabrata, where the Ire1-mediated ER stress response appears to be independent 
of HAC1 splicing26,27. Therefore, it would be interesting to assess how these slight 
modifications in UPR signaling alter the response to ER stress signaling and whether 
hyperactivation of TORC1 signaling also sensitizes these pathogenic fungi to ER stress 
and antifungal drugs.  
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Hyperactive TORC1 signaling may compromise cell wall architecture by impairing 
Swi4/6 signaling. This disruption in cell wall integrity increases sensitivity to 
endoplasmic reticulum stress.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Proposed model of the cellular response to hyperactive of TORC1 
92 
 
If hyperactivation of TORC1 signaling does sensitize pathogenic fungi to ER stress, 
another future direction of our study would be to design a therapeutic approach for 
TORC1 hyperactivation. Interestingly, previous studies in mammalian cells28, 
Drosophila29, Schizosaccharomyces pombe30, and Saccharomyces cerevisiae31 have 
implicated the Rag family of GTPases, Gtr1 and Gtr2, in the activation of TORC1 
signaling. These studies indicate that Vam6, a GTP exchange factor (GEF), colocalizes 
with Gtr1 and TORC1 at the vacuole membrane and controls TORC1 by activating 
Gtr132–35. Additionally, assessment of nucleotide restricted GTR1 and GTR2 alleles 
revealed that GTP-loaded Gtr1 and GDP-loaded Gtr2 stimulate TORC1 and GDP-loaded 
Gtr1 has a dominant negative phenotype31. Furthermore, GTP-loaded Gtr1 physically 
interacts with the Tco89 subunit of the TORC1 complex, suggesting that Gtr1 
specifically controls TORC1 function31. Interestingly, overexpressing Vam6 rendered 
wild-type yeast cells resistant to low rapamycin concentrations and suppressed the semi-
dominant growth defect resulting from GDP-loaded Gtr131. Taken together, these results 
indicate that overexpressing the Vam6 GEF or inhibiting GTP hydrolysis may both be 
mechanisms to hyperactive TORC1 signaling in an antifungal context. Therefore, future 
experiments can assess the druggability of Vam6 or Gtr1 and examine them as potential 
activators of TORC1 signaling and novel targets for antifungal therapies. 
Interestingly, the connection between TORC1 signaling and pathogenic fungal infections 
has been characterized through the use of the TORC1 inhibitor, rapamycin. In particular, 
rapamycin exerted growth inhibitory activity against Mucor circinelloides – an 
opportunistic fungal pathogen that infects patients with diabetes mellitus and solid organ 
transplants36. Similarly, other studies demonstrated that rapamycin has potent antifungal 
activity against C. albicans and  C. neoformans through FKBP12-mediated inhibition of 
the Tor1 protein kinase37. As a whole, these observations suggest that TORC1 activation 
is required for fungal virulence, and that inhibition of TORC1 activity has potent 
antifungal effects. Additionally, our study in budding yeast demonstrated that TORC1 
signaling needs to be properly regulated under conditions of cell stress and that inhibition 
of TORC1 signaling exacerbates toxicity to canonical ER stressors. Given that 
pathogenic fungi are constantly exposed to environmental stressors, exploring how 
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inhibition of TORC1 signaling affects cell stress response pathways may be an interesting 
avenue of study.  
Conversely, recent findings in C. albicans support the model wherein the Tor1 protein 
kinase negatively regulates cellular adhesion38. Activation of Tor1 blocks cellular 
aggregation by promoting expression of adhesion transcriptional repressors, whereas 
inhibition of Tor1 activity, either during nutrient limiting conditions or rapamycin 
treatment, leads to expression of adhesion genes and formation of cellular aggregations, 
processes that are vital for C. albicans virulence traits such as niche colonization and 
biofilm secretion38. Taken together, these findings suggest that hyperactivation may also 
be a useful technique to inhibit virulence of pathogenic fungi. In essence, TORC1 activity 
may differentially mediate virulence traits in different fungal strains, such that inhibition 
of TOR may prove to be more efficacious against some fungal strains, whereas 
hyperactivation of TORC1 signaling may prove to have more portent antifungal activity 
in other strains. Nevertheless, the regulation of TORC1 signaling is an essential 
component of disease propagation, thus further work is required to examine how this 
nutrient-sensing pathway acts in parallel with ER stress response pathways to mediate 
cellular homeostasis. 
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